In a new partnership with Exact Sciences, Workflow Services brings the power of its platform—a full spectrum, front-to-back digital solution supporting point-of-care service delivery—to help educate eligible patients who visit the pharmacy on the importance of having a colorectal cancer screening. For eligible and interested customers, pharmacists are then enabled to help patients learn more about the Cologuard® test from Exact Sciences.

Workflow Services marked a major milestone in its partnership with the FDA in its groundbreaking Diagnostic Data Program. In the 100 days since the FDA selected Workflow Services as its partner to collect data from point-of-care tests administered across U.S. pharmacies, Workflow Services has grown their footprint of users, built partnerships with industry trade organizations and test manufacturers, and added talent to its team.

Workflow Services by ImageMover's CEO Kevin Houlihan and Chief Operating Officer Elise Miller Hoffman discuss the growth and momentum 100 days after being selected as a partner for the FDA's Diagnostic Data Program.

Workflow Services, an automated platform that solves point-of-care clinical service delivery for pharmacies, announced a set of new leadership positions as it accelerates its footprint and scales its solution at pharmacies across the country.

Workflow Services announced a collaboration with CPESN® USA, a clinically integrated, nationwide organization of pharmacy networks established to advance community-based pharmacy practice. In this new collaboration, community-based pharmacies in the CPESN network will have access to the Workflow Services platform, a full spectrum, front-to-back digital solution to help support medical billing for point-of-care service delivery inside pharmacies.

In a short video, CEO Kevin Houlihan discusses Workflow Services’ partnership with the FDA as part of its Diagnostic Data Program. Watch the video or read the transcript to hear Houlihan outline the program's urgency and opportunity for pharmacies, providers, patients, and communities.

Workflow Services, a comprehensive and automated platform that solves point-of-care clinical service delivery for pharmacies, was selected by the Food and Drug Administration (FDA) as a partner in its Diagnostic Data Program, launched to collect data from POC tests administered nationally in pharmacy settings.

Authored by Nancy Gagliano, MD, a former NIH official and current advisor to Workflow Services, the paper maps the complicated state-by-state regulations for pharmacies to deliver clinical services, which grew in scope during the pandemic for services such as test-to-treat therapies. Dr. Gagliano argues that the path to delivering point-of-care services in pharmacy healthcare has been unclear—but not impossible. She advocates for pharmacists to access a suite of tools that deliver end-to-end clinical services.

Workflow Services announces its partnership with the Federation of Pharmacy Networks (FPN), a renowned association of independent pharmacies. This collaboration is designed to empower FPN member organizations with a cutting-edge platform for managing clinical service delivery in pharmacies. The innovative solution enables pharmacies to deliver seamless, pharmacist-led, low-acuity services to their communities while ensuring streamlined reimbursement from medical insurance payers.

Workflow Services announces partnership with QuidelOrtho, a leading provider of point-of-care diagnostic testing solutions, to bring a comprehensive solution for pharmacist-administered testing for a variety of illnesses, including COVID-19, influenza A+B, Lyme disease, strep throat, and RSV.

Workflow Services, a comprehensive and automated platform that solves point-of-care clinical service delivery for pharmacies, announced a new partnership with Uh-Oh Labs (UOL), a US-based, NIH-funded diagnostics and health tech company that enables simplicity, speed, and lower costs while providing accurate, lab-grade results.

Workflow Services, a comprehensive and automated platform that facilitates point-of-care clinical service delivery for pharmacies has partnered with one of the nation’s largest retail pharmacies to enable diagnostic testing for strep and a combination of COVID-19/flu tests in 250 stores in Michigan.

MicroGEM and Workflow Services by ImageMover Join Forces to Provide a Comprehensive Solution for Fast Saliva PCR SARS-CoV-2 Testing at the Point of Care

Southeastern Grocers partners with Workflow Services by ImageMover to provide point-of-care testing in all Winn-Dixie pharmacies

Friendship Public Charter School District in Washington DC partnered with ImageMover to use the Becton Dickinson Veritor System to address their COVID-19 testing throughput efficiency and high amounts of administrative time spent on result communication & reporting to local/federal authorities. Through this partnership, Friendship Schools was able to increase the number of tests they are performing, reduce administrative time by 75%, and return to the focus of their mission - growing and motivating their students.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-2 antigen testing results performed on the BD Veritor™ Plus System at everyday testing locations, such as schools and businesses. The ImageMover app is available immediately for BD Veritor™ Plus System customers.

The Lancashire & South Cumbria NHS Foundation Trust is pioneering point-of-care testing techniques to provide COVID testing at scale. Leveraging technology developed by BridgeHead and ImageMover, Lancashire & South Cambria Trust is performing point-of-care COVID testing with a streamlined mobile application that removes inefficient paper workflows, enabling more capacity for testing, increasing patient throughput, and reducing the need for retesting.

The COVID-19 pandemic has upended life for everyone in the world and has us all wondering how to get back to normal. Regular, frequent, testing at scale is recommended as the foundation for a safe social reopening of our society and economy by the Edmond J. Safra Center For Ethics at Harvard University.1 While testing and tracking are important tactics for pandemic management, there are wild inconsistencies in the approach. Many organizations wishing to reopen don’t have experience testing, tracking, and reporting test results. While there are multiple different sectors challenged by COVID-19 testing, we’ve recently been supporting colleges and universities, and have insights to share. Although these institutions have unique requirements to get their students back on campus and athletes back on the field, many of the principles and approaches they’re employing are widely applicable across society and the economy.